HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November ...

Introduction: Hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis (CA) have similar features on transthoracic echocardiography (TTE) which may make the two difficult to distinguish. However, it ...

Cardiac Amyloidosis is an infiltrative cardiomyopathy in which abnormal ... requiring only a single apical 4-chamber echo video clip. In a subgroup analysis matched for age, sex, and ventricular ...

Cardiac Amyloidosis is an infiltrative cardiomyopathy in which abnormal precursor proteins ... requiring only a single apical 4-chamber echo video clip. Ultromics’ medical devices are software-only, ...

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...

Amvuttra, a treatment for the nerve damage caused by transthyretin amyloidosis led this growth ... Despite elevated expenses, these investments echo Alnylam’s pursuit of its broader strategic ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...